Amgen is a leading human therapeutics company in the biotechnology industry. Since 1980, the company has tapped the power of scientific discovery and innovation to improve people s lives. Products include Aranesp, Enbrel, EPOGEN, Kepivance, Kineret, Neulasta, NEUPOGEN and Sensipar. Amgen pioneered the development of novel products based on advances in recombinant DNA and molecular biology and launched the biotechnology industry s first blockbuster medicines. As a Fortune 500 company serving millions of patients, Amgen continues to be an entrepreneurial, science-driven enterprise dedicated to helping people fight serious illness. The company, which trades on NASDAQ under the ticker symbol AMGN, has a location in Thousand Oaks, Calif.